Intratympanic steroids as primary treatment for sudden sensorineural hearing loss

Soumick Ranjan Sahoo; Pallavi Nayak; Nilanjan Datta

doi:10.18203/issn.2454-5929.ijohns20263390

Authors

Soumick Ranjan Sahoo Department of ENT, Steel Authority of India Limited, IISCO Steel Plant, Burnpur Hospital, Burdwan, West Bengal, India
Pallavi Nayak Department of ENT, Steel Authority of India Limited, IISCO Steel Plant, Burnpur Hospital, Burdwan, West Bengal, India
Nilanjan Datta Department of ENT, Steel Authority of India Limited, IISCO Steel Plant, Burnpur Hospital, Burdwan, West Bengal, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20263390

Keywords:

Sudden, Sensorineural, Intratympanic, Steroids

Abstract

Sudden sensorineural hearing loss (SSNHL) is an otological emergency which demands immediate treatment. It is a rare condition which goes unnoticed because of lack of awareness about this condition among the people and healthcare professionals. SSNHL is considered to be idiopathic but some researchers have reported viral infections, vascular insufficiency, intra labyrinthine membrane rupture etc. as possible etiologies. There are various treatments modalities described in literature such as are steroids, antivirals, vasodilators, hyperbaric oxygen therapy etc. Steroids are one of the most common treatment modalities used for SSNHL. Intratympanic administration of steroids is beneficial because they help in hearing loss recovery while bypassing the side effects of systemic steroids. Our study is a retrospective study of the 15 cases of SSNHL treated by intratympanic steroids in the ENT Department of Burnpur Hospital from 2022-2025. The study reported more number of males with SSNHL. Most of the cases were seen in the age group of 61-70 years. Hearing recovery was seen in 73.3% of the cases. It is concluded that Intratympanic administration of steroids are a novel modality of treatment for cases of SSNHL and awareness of this condition must be created among the public and medical practitioners.

References

de Kleyn A. Sudden complete or partial loss of function of octavus-system in apparently normal persons. Acta Otolaryngica (Stoch). 1944;32:407-29.

Kanotra S, Kumar A, Langar B, Kalsotra P, Paul J. Intratympanic Dexamethasone in Sudden Sensorineural Hearing Loss. Indian J Otolaryngol Head Neck Surg. 2022;74(3):3947-56.

Solanki KJ, Ghodasara SD, Bhatasana AJ. Efficacy of intratympanic steroid in the management of sudden sensorineural hearing loss: a case series. Int J Res Med Sci. 2026;14:256-60.

Chandershekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: clinical and labortary evaluation. Otoneurology. 2001;22(1):18-23.

Plaza G, Herráiz C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg. 2007;137(1):74-8.

Banerjee A, Parnes LS. Intratympanic corticosteroids for sudden idiopathic sensorineural hearing loss. Otol Neurotol. 2005;26:878-81.

Tejaswini JS, Walia M, Bansal S, Soni S. Efficacy of Oral versus Intratympanic Steroids in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss: A 1-year Randomized Control Trial. Indian J Otol. 2023;29(2):105-10.

Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: Sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146(3):S1-35.

Leung MA, Flaherty A, Zhang JA, Hara J, Barber W, Burgess L. Sudden sensorineural hearing loss: Primary care update. Hawaii J Med Public Health. 2016;75(6):172-4.

Wu CS, Lin HC, Chao PZ. Sudden sensorineural hearing loss: Evidence from Taiwan. Audiol Neurootol. 2006;11(3):151-6.

Byl FM. Sudden hearing loss: eight years-experience and suggested prognostic table. Laryngoscope. 1984;94(5):647-61.

Samor V, Khadav S, Arya P, Deepchand, Dhaka R.The role of intratympanic dexamethasone in sudden sensorineural hearing loss. Int J Otorhinolaryngol Head Neck Surg. 2020;6:821-5.

Chandershekhar SS, Tsai Do BS, Schwartz SR, Laura JB, Erynne AF, Sandra AF, et al. Clinical practice guidelines: sudden hearing loss (update) Otolaryngol Head Neck Surg. 2019;161(2):195-210.

El SN, Sewitch MJ, Bezdjian A, Daniel SJ. Intratympanic dexamethasone in sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope. 2017;127(8):1897-908.

Hong SM, Park CH, Lee JH. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg. 2009;141(5):579-83.

Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007;117(1):3-15.

Wang Y, Gao G, Wang L, Ma X, Yu L, Ye F. Association Between the Number of Intratympanic Steroid Injections and Hearing Recovery in Sudden Sensorineural Hearing Loss. Front Neurol. 2021;12:798569.

Silverstein H, Choo D, Rosenberg SI, Kuhn J, Seidman M, Stein I. Intratympanic steroid treatment of inner ear dis ease and tinnitus (preliminary report). Ear Nose Throat J. 1996;75:468-71.

Kopke RD, Hoffer ME, Wester D, O’Leary MJ, Jackson RL. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol. 2001;22:475-9.

Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of con ventional therapy: a pilot study. Acta Otolaryngol. 2002;122(7):698-702.

Amizadeh M, Fazlinezhad F, Ranjbar M, Mahdieh H. The efficacy of methylprednisolone acetate nanogel in treating patients with sudden sensorineural hearing loss. Sci Rep. 2025;15(1):12342.